Jennifer Buenviaje

Statistics

Publications

Citations

218

H-Index

Active since

2014

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jennifer Buenviaje is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicinal chemistry, and optimization of drug-like properties.

Publications per year

2014–2023

Publications

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

Kelli Kuhen, Arnab K. Chatterjee, Matthias Rottmann et al. · Antimicrobial Agents and Chemotherapy · 2014 · 158 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation

Stephen H. Norris, Xiaochu Ba, Jayce Rhodes et al. · Journal of Medicinal Chemistry · 2023 · 50 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)

Young Chen, Brandon Whitefield, Erin Nevius et al. · Journal of Medicinal Chemistry · 2023 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +16

1–3 of 3